Primary study · included by 1 review
Association of Radioactive Iodine Administration With Outcome Among Patients With Low-Risk Differentiated Thyroid Cancer: A Real-World Data Analysis.
Xu 2024 · Xu Yang, Huang Peiyin, Wang Liying, et al. · Clinical endocrinology · 2025
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Recurrence Radioactive iodine (RAI) ablation after total thyroidectomy vs No RAI (total thyroidectomy alone) | OR 0.66 [0.41, 1.08] | 7 studies · 4101 participants | GRADE not reported |
5-year recurrence-free survival Radioactive iodine (RAI) ablation after total thyroidectomy vs No RAI (total thyroidectomy alone) · 5 years | OR 4.70 [1.39, 15.97] | 3 studies · 2493 participants | GRADE not reported |
5-year recurrence-free survival Radioactive iodine (RAI) ablation after total thyroidectomy vs No RAI (total thyroidectomy alone) · 5 years | OR 2.47 [0.63, 9.62] | 4 studies · 2997 participants | GRADE not reported |
1 including review in total.